Q2 2023 13F Holders as of 6/30/2023
-
Type / Class
-
Equity / COM
-
Number of holders
-
11
-
Total 13F shares, excl. options
-
520K
-
Shares change
-
+86K
-
Total reported value, excl. options
-
$140K
-
Value change
-
+$22.7K
-
Number of buys
-
1
-
Number of sells
-
-1
-
Price
-
$0.27
Significant Holders of CytoDyn Inc. - COM (CYDY) as of Q2 2023
11 filings reported holding CYDY - CytoDyn Inc. - COM as of Q2 2023.
CytoDyn Inc. - COM (CYDY) has 11 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 520K shares
.
Largest 10 shareholders include Firsthand Capital Management, Inc. (223K shares), Capital Advantage, Inc. (91K shares), Diversified Trust Co (45.8K shares), Next Capital Management LLC (37.5K shares), Associated Banc-Corp (29.1K shares), Moloney Securities Asset Management, LLC (28K shares), MONOGRAPH WEALTH ADVISORS, LLC (24K shares), FineMark National Bank & Trust (15K shares), Willis Investment Counsel (13K shares), and Ancora Advisors, LLC (9.49K shares).
This table shows the top 11 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.